Blog

Cureus | The 36-Month Survival Analysis of Conservative Treatment Using Platelet-Rich Plasma Enhanced With Injectable Platelet-Rich Fibrin in Patients With Knee Osteoarthritis

Why publish in Cureus? Click below to find out.

Unlock discounted publishing that highlights your organization and the peer-reviewed research and clinical experiences it produces. Pure Prp

Cureus | The 36-Month Survival Analysis of Conservative Treatment Using Platelet-Rich Plasma Enhanced With Injectable Platelet-Rich Fibrin in Patients With Knee Osteoarthritis

Offering a variety of advertising and sponsorship options for reaching influential specialists from targeted demographic splits.

Cureus provides an equitable, efficient publishing and peer reviewing experience without sacrificing publication times.

Why publish in Cureus? Click below to find out.

Unlock discounted publishing that highlights your organization and the peer-reviewed research and clinical experiences it produces.

Offering a variety of advertising and sponsorship options for reaching influential specialists from targeted demographic splits.

Cureus provides an equitable, efficient publishing and peer reviewing experience without sacrificing publication times.

Please note that by doing so you agree to be added to our monthly email newsletter distribution list.

Cureus | The 36-Month Survival Analysis of Conservative Treatment Using Platelet-Rich Plasma Enhanced With Injectable Platelet-Rich Fibrin in Patients With Knee Osteoarthritis

Prp Tube Price By joining Cureus, you agree to our Privacy Policy and Terms of Use.